Disseminated necrotizing leukoencephalopathy eight months after alemtuzumab treatment for multiple sclerosis.

Authors :: Metz I
Rieckmann P
Kallmann BA
Brück W
Source :: Acta neuropathologica communications [Acta Neuropathol Commun] 2016 Aug 08; Vol. 4 (1), pp. 81. Date of Electronic Publication: 2016 Aug 08.
Publication Year :: 2016

Subjects :: Adult
Alemtuzumab therapeutic use
Brain drug effects
Brain pathology
Fatal Outcome
Female
Humans
Immunologic Factors therapeutic use
Leukoencephalopathies pathology
Multiple Sclerosis, Relapsing-Remitting pathology
Alemtuzumab adverse effects
Immunologic Factors adverse effects
Leukoencephalopathies complications
Multiple Sclerosis, Relapsing-Remitting drug therapy

Full Text Access

Tools